Lv1
50 积分 2025-04-14 加入
A human iPSC-derived sensory neuron platform for high-throughput discovery of neuroprotectants against chemotherapy-induced peripheral neuropathy
10天前
已完结
Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer
3个月前
已完结
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial
3个月前
已完结
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
8个月前
已完结
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial
10个月前
已完结
Mitochondrial Mg²⁺ homeostasis decides energy metabolism and cell death
1年前
已完结
Glucose Metabolism‐Targeted Poly(amino acid) Nanoformulation of Oxaliplatin(IV)‐Aspirin Prodrug for Enhanced Chemo‐Immunotherapy
1年前
已完结
NRF2 activation prevents oxaliplatin-induced peripheral neuropathy by preserving mitochondrial complex I function in dorsal root ganglion neurons
1年前
已完结
Single-cell profiling reveals distinct adaptive immune signatures in the dorsal root ganglia in response to oxaliplatin-induced peripheral neuropathy
1年前
已关闭
Oxaliplatin causes sensory neuropathy by inducing damage of mitochondrial complex I-dependent electron transport chain in dorsal root ganglia
1年前
已关闭
皖公网安备34019202002308
